3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Phase 2
1
Status
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
CNS
3
Conditions
Oligodendroglioma
1
Medulloblastoma
1
Glioma
1
Brain Neoplasms
1
Interventions
Specimen Handling
149
pembrolizumab
130
Magnetic Resonance Spectroscopy
120
Cyclophosphamide
117
Biopsy
102
fludarabine
89
Nivolumab
58
Carboplatin
53
Cisplatin
48
Radiotherapy
46
Gemcitabine
46
venetoclax
43
Paclitaxel
41
Cetuximab
41
fludarabine phosphate
39
Ipilimumab
35
atezolizumab
34
Fluorouracil
34
Bevacizumab
33
durvalumab
29
Radiation
28
Oxaliplatin
28
Leucovorin
28
Dexamethasone
28
X-Rays
26
Irinotecan
26
Cytarabine
26
Azacitidine
26
Radiosurgery
24
Injections
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 1
×
Diphtheria-Tetanus Vaccine
×
90 days
×
Clear all
NCT06254326
2026-05-27
ADAGiO
University of Florida
Phase 1
Recruiting
12 enrolled
NCT03334305
2026-04-23
ACTION
University of Florida
Phase 1
Terminated
18 enrolled
11 charts
NCT06514898
2026-04-03
MATCHPOINT
University of Florida
Phase 1
Active not recruiting
12 enrolled